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Abstract
Intracellular bacteria such as Anaplasma spp. and Mycobacterium spp. pose a risk to 
human and animal populations worldwide. The main function of immune response 
cells is to eliminate invading pathogens. However, pathogens can deregulate host cell 
function and turn defense cells into suitable hosts. Intracellular bacterial have a smaller 
genome, compared to the host cell, thus requiring efficient mechanisms for survival and 
persistence within the host by inducing sustained changes in cell function and immune 
response. Bacterial epigenetic regulation of host cell gene transcription appears to be a 
general mechanism that enhances pathogen survival while altering host cell function and 
facilitating infection. Anaplasma phagocytophilum leads to modified host cell gene tran-
scription and phenotype by epigenetically altering host chromatin. Mycobacterial infec-
tion of human cells also results in host gene silencing using a mechanism that involves 
HDAC complex formation and histone deacetylation. Membrane proteins are essential 
for cell invasion in both pathogens, and can regulate and protect the pathogen against 
the host response. Understanding the mechanisms employed by these bacteria to infect 
the host could contribute to develop effective interventions for the control of tuberculo-
sis and anaplasmosis. This review focuses on the common strategies employed by two 
zoonotic pathogens, Anaplasma and Mycobacterium spp., highlighting also the different 
mechanisms used to infect host cells.
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1. Introduction
Ticks and tick-borne diseases represent a growing problem for human and animal health 
worldwide whereas tuberculosis continues to be a global burden in both human and ani-
mal populations [1, 2]. Pathogenic organisms have evolved host mimicking properties 
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and manipulate host responses for their own survival and propagation. To successfully 
establish and maintain a bacterial infection, the pathogens subvert the host cells defense 
response to survive, proliferate, and persist within the infected cell. To evade host defense 
systems, bacterial pathogens produce a variety of virulence factors that stimulate bacterial 
adherence and invasion and subvert host cell signaling cascades that regulate intracellu-
lar microbial survival and trafficking. Some of these mechanisms are mediated by factors 
released by the bacteria, whereas others rely on hijacking host components to prevent the 
production of an effective immune response thus promoting their survival within the host 
cell [2, 3]. Intracellular bacteria from Anaplasma and Mycobacterium genera produce similar 
genes expression patterns in infected ruminants [4]. Pathogen and host-specific differences 
could contribute to disease diagnosis and treatment of tuberculosis and anaplasmosis in 
ruminants.
In this review, we provide an overview of some of the mechanisms employed by Anaplasma 
and Mycobacterium to infect the host cell and the impact on their pathogenesis.
2. Anaplasma phagocytophilum, an intracellular bacterium with unusual 
tropism
The emergence of tick-borne pathogens has been promoted by the exploitation of envi-
ronmental resources and the increase in human outdoor activities, allowing the contact 
with tick vectors normally present in the field [5]. Anaplasma phagocytophilum is an obligate 
intracellular rickettsial pathogen transmitted mainly by Ixodes spp. ticks causing human 
granulocytic anaplasmosis (HGA), equine, and canine granulocytic anaplasmosis, and 
tick-borne fever (TBF) in ruminants [6]. In the vertebrate host, A. phagocytophilum infects 
neutrophils where the pathogen multiplies within a parasitophorous vacuole or morula 
in the cytoplasm of tick and vertebrate host cells [7, 8]. These gram-negative bacteria are 
grouped within the family Anaplasmataceae [3]. Complications and fatality are rare but 
more common in the elderly, the immunocompromised, or if proper diagnosis and/or 
antibiotic therapy are delayed. Fatalities are usually not directly attributed to the infection 
itself; pathological findings suggest defects in host defense and the presence of secondary 
infections [9]. However, the severity of illness and fatality rates could also be due to under-
lying immunosuppression.
Anaplasma is a highly antigenically variant bacterial pathogen that displays a diversity of 
mechanisms to create the structural and antigenic variation necessary to escape the immune 
response and allows long-term persistence in the host thus being able to act as a reservoir for 
transmission. A. phagocytophilum strategies to infect vertebrate host cells include, among oth-
ers, remodeling of the cytoskeleton, inhibition of cell apoptosis, manipulation of the immune 
response and modification of cell epigenetics and metabolism [10]. Hosts respond to infection 
by activating alternative pathways to regulate cell apoptosis, immunity, metabolism and stress 
response mediated by heat-shock proteins (Hsps) [1]. Unlike other bacteria, A. phagocytophilum 
is aflagellated and does not have a type III secretion system (T3SS) [11, 12].
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Pathogens subvert cellular immune response to favor infection and multiplication. Host cell 
transcriptome and proteome studies have demonstrated an effect of A. phagocytophilum infec-
tion on the inhibition of cell innate immunity [13–15]. They employ a variety of mechanisms 
to create the structural and antigenic variation needed to subvert the host immune system and 
long-term persistence [3]. A. phagocytophilum also employs a type IV secretion system (T4SS) 
to deliver proteins or DNA into eukaryotic cells [16]. It also inhibits host cell apoptosis to 
allow the bacteria sufficient time to develop morulae [17].
Adaptation to a life in eukaryotic cells and transmission between hosts has been assisted by 
the deletion of many genes that are present in the genomes of free-living bacteria, includ-
ing genes required for the biosynthesis of lipopolysaccharide and peptidoglycan that are 
involved in the activation of host leukocytes [18].
P44 (also known as MSP2) is a highly variable immunodominant surface protein that facilitates 
adherence to granulocytes [19]. The genome of Anaplasma consists of more than 100 msp2(p44) 
paralogs [20]. Antibodies specific to P44 inhibit A. phagocytophilum infection in mice and HL-60 
cells, which suggests that antigenic variation of P44 proteins may help A. phagocytophilum to 
escape host immune surveillance [3]. Some Anaplasma strains are naturally persistent in lambs 
and can be used to analyze the mechanisms of persistence in the vertebrate host. Variation 
of the outer membrane protein MSP2(P44) is believed to play a key role in persistence of the 
organism [21].
A. phagocytophilum can avoid killing by innate immunity but it also induces some innate 
immune responses, such as the production of IFN-γ, that contribute to tissue injury and dis-
ease [22]. Signal transducer and activator of transcription 1 (Stat1) is important in host innate 
and adaptive immune responses to intracellular pathogens, including intracellular bacteria 
[23]. It mediates most of the biological functions of both type I interferon (IFNα/β) and type 
II IFN (IFNγ). A. phagocytophilum infection-induced IFNγ signaling leads to phosphorylation 
of Stat1 in mice and is critical for the generation of protection [24]. Experimental infections 
with mice have demonstrated that the absence of Stat1 converts the subclinical infection to 
a severe one [22] suggesting that Stat1 plays an important role in controlling the response to 
bacterial infections. Stat1 also participates in the IFN-γ signaling of mycobacterial immunity. 
IFN-γ signaling provides positive feedback to both macrophages and CD4+ T-cells, which 
amplifies the Th1 response [25]. Suppressor of cytokine signaling (SOCS) expression has been 
implicated in intracellular survival of A. phagocytophilum in neutrophils where expression of 
IFN-γ receptor alpha-chain CD119 is diminished leading to reduced Stat1 dimerization and 
signaling [26].
In neutrophils, the genes most downregulated in response to A. phagocytophilum infection 
include those coding for proteins involved in bacterial killing such as myeloperoxidase, 
transferrin, bactericidal/permeability-increasing protein and cell protection (mucin 12). 
Immune-system-related genes encoding interferons, cytokines, chemokines, and their recep-
tors are upregulated in response to infection [13–15]. This suggests that pathogens have 
developed mechanisms to subvert the innate immune protective mechanisms in vertebrate 
hosts. However, some species can activate innate immune protective mechanisms to  control 
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 infection and appear to play a minor role as reservoir hosts for the pathogen [27]. For instance, 
pigs naturally and experimentally infected with A. phagocytophilum control bacterial infection 
through activation of innate immune responses, phagocytosis, and autophagy [28] resulting 
in low infection levels or infection clearance.
A. phagocytophilum, a pathogen lacking the T3SS and flagellin, activates the NLRC4 inflamma-
some (a component of the innate immune system) and secretion of IL-1β [29]. IL-18 release 
mediated by the NLRC4 inflammasome regulates IFN-γ production by CD4+ T cells upon 
A. phagocytophilum infection [30]. The receptor-interacting serine/threonine-protein kinase 2 
(RIPK2) appears to be a major regulator of the immune response against A. phagocytophilum. 
Ripk2−/− immune cells exhibit a defect in activation for the nuclear factor (NF)-κB and the 
NLRC4 inflammasome pathways [29]. Furthermore, experimental mice lacking COX2 (cyclo-
oxygenase 2) are more susceptible to A. phagocytophilum, they do not secrete IL-18 and exhibit 
splenomegaly and damage to the splenic architecture [29].
A. phagocytophilum transiently infects bone-marrow derived macrophages (BMDMs) [31] 
and clinical features in animal models and infected patients suggest classical macrophage 
activation [32]. Deep sequencing analysis of experimentally infected macrophages indi-
cated that the transcription of genes that encode for phospholipase A2 (pla2g12a, pla2g5 
and pla2g2e), COX2 and PGE synthase (ptges) was increased upon A. phagocytophilum 
infection [29].
A. phagocytophilum use heat shock proteins (Hsps) for infection of vertebrate host cells [33, 34]. 
Host cells can also activate Hsps in response to infection [35–37]. The mammalian immune 
response against pathogen Hsps to control infection may trigger a detrimental autoimmune 
response to host Hsps [35, 36, 38]. However, recent evidence suggests that hosts may benefit 
from induction of Hsps in response to pathogen infection [1]. A mutant strain of Mycobacterium 
tuberculosis, that constitutively over produced Hsp70 proteins, was fully virulent in the initial 
stage of infection, but its survival was reduced in the chronic phase. This suggests that induc-
tion of microbial genes encoding Hsps might provide a novel strategy to boost the immune 
response of individuals with latent infections [39].
How A. phagocytophilum interacts with the mammalian immune system is still unclear. Both T 
and B cells have been shown to play important roles in the control and clearance of A. phago-
cytophilum [40, 41]. CD4+ T cells and T-helper 1 (Th1) play a key role in the immune response 
to the infection of A. phagocytophilum [30, 42]. IFNγ, IL-12, and IL-18 also play important roles 
in the early clearance of A. phagocytophilum [30, 43]. Well-known anti-bacterial innate immune 
detection system such as TLR2, TLR4, and their adaptor MyD88 appear to play no role in the 
immune response to A. phagocytophilum infection [41]. Some studies suggest that signaling 
through the Nod Like Receptor (NLR) family member IPAF (NLRC4), its adaptor ASC, and 
Caspase-1 is critical for the control of A. phagocytophilum infection during the early phase of 
infection [30].
Rip2 has been previously shown to play an essential role in the immunity against vari-
ous intracellular pathogens including Mycobacterium tuberculosis [44]. Rip2 also plays an 
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important role in the control of A. phagocytophilum infection [44]. A. phagocytophilum infec-
tion upregulates Rip2, the adaptor molecule of the cytoplasmic pattern recognition receptor 
Nod1 and 2 in immune cells [45]. Following peptidoglycan detection, Nod1/Nod2 recruit 
and associate with the adaptor protein Rip2, triggering proinflammatory signaling path-
ways via NF-κB and the mitogen-activated protein (MAP) kinases p38, JNK, and ERK [46]. 
IL-8, a major inflammatory chemokine, is heavily induced during A. phagocytophilum infec-
tion in humans [47]. Trafficking of neutrophils to the sites of infection is induced by this che-
mokine and Rip2, which appears to play an important role in neutrophil recruitment in vivo 
[48]. IFN-γ, another inflammatory cytokine, plays a major role in the immune pathology 
and early clearance of A. phagocytophilum infection [43]. It is also known that an adaptive 
CD4+ T cell mediated response is critical for the complete clearance of A. phagocytophilum 
infection [42]. Previous reports have shown the importance of natural killer (NK) cells, NKT 
cells [49] and CD4 + T cells [42] in the IFNγ production and host defense to A. phagocytophi-
lum infection (Figure 1).
Using oligonucleotide array technology [50], it was observed that genes involved in the 
immune response were modulated in neutrophils infected with A. phagocytophilum. Among 
the genes that were most upregulated in the early transcriptional response to infection in 
neutrophils were cytokines, chemokines, and their receptors (e.g., CCL3, CCL3L3, IL-8, IL-1β, 
and CXCR4).
The major adipocyte lipid droplet-associated phosphoprotein perilipin (PLIN) is upreg-
ulated in HL60 infected cells. Both protein and mRNA levels were higher in infected 
cells and the over expression of PLIN was parallel with bacterial infection levels [51]. 
Furthermore, PLIN knockdown resulted in a reduction of A. phagocytophilum infection in 
HL60 cells, suggesting the bacteria modulate host lipid metabolism to infect and multiply 
in the host cell [51].
In THP-1 cells, A, phagocytophilum infection displays an upregulation of histone deacety-
lates 1 and 2 (HDAC1 and HDAC2), while protein levels exhibit a similar kinetic pattern 
for both HDACs. Moreover, pharmacological inhibition of HDAC and HDAC1 silenc-
ing reduced the level of bacterial infection in THP-1 cells [52]. Mycobacterial infection of 
THP-1 cells specifically inhibits HLA-DR gene expression by a pathway involving HDAC 
complex formation at the HLA-DR promoter, resulting in histone deacetylation and gene 
silencing [53].
Proteins secreted by bacteria are involved in many important tasks and they account for many 
of the virulence factors of pathogens. Outer membrane protein A (OmpA), also known as 
peptidoglycan-associated lipoprotein, is conserved among most Gram-negative bacteria and 
interacts with peptidoglycan to maintain outer membrane integrity [54]. The expression of 
OmpA increases in the early stages of infection. OmpA is presented on the pathogen’s surface 
and is upregulated during invasion of HL-60 cells. Sera from HGA patients and experimen-
tally infected mice recognize recombinant OmpA. Pretreatment of A. phagocytophilum organ-
isms with OmpA antiserum reduces their ability to infect HL-60 cells [54].
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A. phagocytophilum uses surface proteins invasins OmpA, Asp14, and AipA to bind and infect 
mammalian hosts [55, 56]. OmpA interacts with α1,3-fucose, which is critical for the bacteria 
to bind host cell surfaces and invade them. OmpA, Asp14, and AipA play essential roles in 
the A. phagocytophilum lifecycle [54, 55, 57]. Directing the immune response to their binding 
domains could enhance protective efficacy. It has been observed that an antibody cocktail 
Figure 1. A. phagocytophilum and M. tuberculosis employ common strategies but different mechanisms to infect host 
cells: Nod proteins activate NF-κB through the serine–threonine kinase Rip2. NF-κB is translocated to the nucleus and 
stimulates cytokine expression. Secretion of IL-8 stimulates neutrophil and T cell migration. Stat1 participates in the 
IFN-γ signaling of intracellular bacteria. (A). Neutrophil infected with A. phagocytophilum: IFN-γ contributes to tissue 
injury and disease. AnkA is secreted by the bacteria and translocates to the nucleus of infected cells regulating host cell 
transcription facilitating intracellular bacterial survival and growth. (B). Macrophage infected with M. tuberculosis: IFN-γ 
activates macrophage phagocytosis killing intracellular bacteria. TNF-α attracts macrophages and lymphocytes at the 
site of infection and promotes granuloma formation thus resulting in limited antigen presentation.
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specific for the OmpA, Asp14, and AipA binding domains blocked A. phagocytophilum infec-
tion of host cells [56]. This finding could help the development of an anti-multi-invasin vac-
cine to protect against human and veterinary granulocytic anaplasmosis or even against 
other obligate intracellular pathogens such as Mycobacterium spp. since they also use mul-
tiple invasins to enter host cells [58].
MSP1a and MSP1b from Anaplasma marginale have been shown to be adhesins for host cells 
[59]. Studies on the immunogenicity of recombinant BCG expressing the MSP1a antigen sug-
gested that the immune responses were influenced by the level of antigen expression [60]. 
These results indicated that recombinant M. bovis BCG expressing MSP1a could be used to 
test for protective antibody production for the control of anaplasmosis.
The A. phagocytophilum genome encodes a type four secretion system (T4SS) that may facili-
tate intracellular survival by translocation of virulence factors that appear to be important for 
the manipulation of the host cell. Ankirin A (AnkA) is a translocated virulence factor that is 
tyrosine-phosphorylated by host cell kinases upon translocation into the host cell early dur-
ing infection [16, 61].
Anaplasma translocation substrate 1 (Ats-1) protein belongs to T4SS of Anaplasma, which is secreted 
and localizes into the mitochondria of human neutrophils and HL60 cells. Ats-1 translocates 
to the host cell mitochondria matrix via the translocase of the outer mitochondrial membrane 
(TOM) complex. Transfection assays with RF/6A and yeast cells demonstrated that Ats-1 inhibits 
etoposide and Bax-induced apoptosis respectively [62] thus facilitating pathogen survival.
In mammalian cells, A. phagocytophilum activates extracellular signal-regulated kinase (Erk)1/2, 
a key protein of the MAP kinase pathway [50, 63]. AptA (Anaplasma phagocytophilum toxin A, 
formerly named APH_0233) stimulates Erk1/2 phosphorylation in HL60 and HEK293 cells 
[64]. Furthermore, AptA interacts with vimentin, and gene silencing and inhibitory enzymatic 
assays in HL60 cells and neutrophils respectively, demonstrated that vimentin is necessary for 
Erk1/2 activation and Anaplasma infection [64].
Anaplasma inclusions have a double-lipid bilayer membrane, and induce autophagosome 
formation in the host cell. Also, beclin 1 and light chain 3 (LC3) proteins that play a cen-
tral role in autophagy are colocalized bacterial replicative inclusions. Furthermore, assays 
of inhibition and induction of this catabolic mechanism in HL60 infected cells demonstrated 
that autophagy benefits infection, rather than elimination [65]. Ref. [66] described that induc-
tion of autophagy in host cells is mediated trough beclin 1 (Becn1) that binds Ats-1 to sup-
ply nutrients for pathogen growth. Additionally, gene silencing of Becn1 inhibits infection in 
mammalian cells [66].
3. The Mycobacterium tuberculosis complex, a global burden for human 
and animal health
Macrophages play a central role in the first line of defense against pathogenic microorgan-
isms, however, they are also the key target cells for mycobacteria. The bacteria can live and 
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replicate inside the macrophages, thus evading the innate immune response against infec-
tion of the host through immunosuppression and immune evasion [53]. Co-evolution of M. 
tuberculosis with its hosts has enabled the pathogen to develop host immune evasion strate-
gies that interfere with both innate and adaptive immunity. These include the manipulation 
of their phagosome within host macrophages, the avoidance of pattern recognition receptors, 
the modulation of host cytokine production, and the manipulation of antigen presentation to 
prevent or alter the quality of T-cell responses [67]. Other mechanisms include interference 
with phagosomal acidification and trafficking, blocking autophagy and apoptosis-mediated 
killing, perturbing calcium signaling, and inhibiting the inflammasome activation in order 
to modulate the host immune responses. Manipulation of these host pathways is achieved 
by bacterial components such as cell wall lipids, serine threonine kinases, phosphatases and 
proteases, and using specialized secretion systems.
The outcome of infection with Mycobacterium tuberculosis depends on the ability of the 
immune response to clear or contain the infection. When this fails, the bacterium replicates, 
disseminates within the host, and elicits a pathologic inflammatory response. Individuals 
infected with M. tuberculosis develop mainly CD4 T cell responses to protein components of 
M. tuberculosis, an immune response that can persist for years. Infections with mycobacteria 
are characterized by their chronic course and, even with an adequate immune response, 
they can persist inside macrophages. Progression to active disease is possible even decades 
after exposure [68] and is typically triggered by immune compromise. Although the bacte-
ria are concealed within the infected macrophage, B cells and antibodies also play a role on 
the immune response to intracellular bacteria and are likely to be important in the control 
of M. tuberculosis [69]. In addition, B cells are a major cellular component of the granuloma 
(an important mechanism of host defense against tuberculosis) where they can process and 
present antigen to T cells, secrete antibodies, and modulate inflammation through the pro-
duction of IL-10 [70]. In vitro human B cells have been shown to ingest mycobacteria, pro-
duce IgM, and upregulate the expression of the costimulatory molecules CD80 and CD86 
and the chemokine CXCL10 [71]. The human CD4 T cell response exhibits Th1-response 
characteristics [72].
Mycobacteria have a distinct secretion system, named type VII (T7SS or ESX), which is 
associated with virulence and pathogenesis, including growth in macrophages [73] and 
antigen presentation. This system is encoded by a locus that is deleted in attenuated strains 
of M. bovis (bacille Calmette–Guérin (BCG) strains), which are used to vaccinate against 
tuberculosis [74].
IL-8 is a chemokine with a significant role in regulating leukocyte influx in TB. In vivo studies 
have shown that pre-treatment with anti-IL-8 alone inhibits mycobacterial granuloma forma-
tion [75]. IL-8 is involved in attracting neutrophils and T cells and in monocyte recruitment 
[76]. Targeting IL-8 secretion during inflammation could be the subject for new therapeutic 
approaches [77].
Mycobacterial components can activate MAP kinase signaling cascades but this activation 
varies depending on the species of Mycobacterium. For instance, it appears to be diminished in 
macrophages infected with pathogenic strains of M. avium [78].
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IFN-γ is a Th1 cytokine that plays a vital role in the protective immune response against M. 
tuberculosis infection [2]. In cattle, IFN-γ is produced predominately by activated CD4 T cells 
following presentation of M. bovis antigens on the surface of antigen presenting cells (APCs) 
[79]. IL-10 is released following phagocytosis of pathogenic mycobacteria [80] and has been 
shown to inhibit the pro-inflammatory cytokine response through down regulation of IL-12 
and IFN-γ [81, 82]. Increased IL-10 levels appear to correlate with progression of infection in 
a bovine tuberculosis model [83] (Figure 1).
Nod proteins and their adaptor molecule Rip2 are key components of a family of cytosolic 
innate immune pattern recognition receptors [84]. Nod2 triggers cytokine production by den-
dritic cells in response to live M. tuberculosis, but is not essential to control infection [85].
M. tuberculosis can use the TLR2 pathway to modify the host environment [86]. The adaptor 
molecule myeloid differentiation factor-88 (MyD88) appears to play a significant role in the 
pathogenesis of Mycobacterium. Mice lacking MyD88 are highly susceptible to M. tuberculosis 
infection, with a mean time to death of approximately 42 days.
Glycolipids are one of the most common cell surface components of macrophages and den-
dritic cells. They interact with intracellular bacteria, estimulating the host immune response 
[87]. LprG (Rv1411c), a cell membrane lipoprotein essential for M. tuberculosis virulence, binds 
to the acyl groups of lipoglycan [88]. In murine macrophage cells (RAW 264.7), LprG is essen-
tial for macrophage entry and inhibition of phagosome—lysosome fusion. Also, it has been 
described that LprG has a significant role in the production of lipoglycan lipoarabinomannan 
(LAM), one of the major cell surface components of M. tuberculosis [87, 89]. LprI is another 
lipoprotein used by M. tuberculosis to bind and inhibit the lytic activity of lysosomes [90].
Mycolic acids are major components of the outer membrane of M. tuberculosis. HadC (Rv0637) 
contributes to mycolic acids biosynthesis and its mutation or silencing is directly related to 
the loss of M. tuberculosis virulence [91].
M. tuberculosis encodes the serine protease Rv2224c (Hip1) that is present on the cellular 
membrane [92]. In primary macrophages, silencing of Hip1 notably decreased mycobacte-
rial growth compared to the wild type bacteria. Moreover, levels of cytokines (TNF-α, IL-1β, 
IL-6) were increased in macrophages infected with wild-type M. tuberculosis compared to the 
mutant Hip1 M. tuberculosis [93]. The stress-induced protein GroEL2 is a substrate for Hip1 
[92]. Hip1 appears to limits dendritic cells cytokine secretion and through under modulation 
of CD40 and CD86, it could affect dendritic cell maturation, and decrease antigen presenta-
tion to CD4 T cells [94].
Transcriptional assays have shown that M. tuberculosis infection of human monocytes activate 
the MAPK pathway to promote over expression of IL-23, that is involved in the modulation 
of Th1/Th17 cells [95]. In addition, it has been reported that the bacteria may suppress the dif-
ferentiation of monocytes into dendritic cells through the release of IL-10 [96].
Intracellular bacteria can manipulate host gene expression through epigenetic modifications to 
help infection and survival inside the host cell. Ghorpade et al. [97] described that M. bovis bacil-
lus Calmette-Guérin (BCG) modify epigenetically nitric oxide and KLF4 to restrain the class II 
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 transactivator (CIITA) and MHC-II expression thereby eluding immune surveillance. Evidence 
supports that M. tuberculosis infection in THP1 cells induces overexpression of HDAC1, which is 
implicated in the downregulation of IL-12B that plays a key role in the Th1 response [98].
Lsr2 is a M. tuberculosis protein with histone-like features, including the ability to regulate a 
variety of transcriptional responses in mycobacteria. Lsr2 protects mycobacteria against reac-
tive oxygen intermediates (ROI) in vitro and during macrophage infection shielding bacterial 
DNA by binding to it [99] suggesting it could be a good candidate as a drug target.
4. Conclusions
Intracellular bacteria such as Anaplasma and Mycobacterium use similar mechanisms to infect 
vertebrate host cells. These strategies include manipulation of the immune response, subver-
sion of phagocyte cells and the use of proteins for infection and manipulation of host gene 
expression. Nevertheless, different pathogens have evolved specific strategies when infecting 
their hosts. Abundantly expressed proteins are often the primary targets of research, how-
ever, less prominently expressed antigens may have equally good or even superior vaccine 
potential. Research into the antigen catalog available for immune recognition of infected cells 
could provide new directions for antigen discovery and vaccine development.
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